Nội dung được dịch bởi AI, chỉ mang tính chất tham khảo
Tình trạng hiện tại của ghép tạng composite có mạch máu
Tóm tắt
Ghép tạng composite có mạch máu (VCA) cung cấp các phương pháp điều trị cho những thiếu hụt chức năng phức tạp mà không thể sửa chữa bằng các phương pháp tái tạo thông thường. VCA bao gồm các khối đơn vị chức năng với nhiều loại mô khác nhau như da, xương, cơ, dây thần kinh, mạch máu, gân, dây chằng và các mô khác, do đó có thành phần hoàn toàn khác biệt so với ghép cơ quan. Lĩnh vực VCA đã có những tiến bộ thú vị trong thời gian gần đây. Trong số các VCA khác nhau, đã có nhiều ca ghép tay, mặt và chi thành công được thực hiện trên toàn thế giới. Đồng thời, một số câu hỏi cụ thể về miễn dịch bẩm sinh và miễn dịch thích ứng, hậu quả của tổn thương thiếu máu/tái tưới máu, ức chế miễn dịch, bảo quản và khả năng tái tạo vẫn đang tồn tại. Mặc dù vậy, lĩnh vực này đang đứng trước cơ hội để có những bước tiến đáng kể trong tương lai gần.
Từ khóa
#Ghép tạng composite có mạch máu #miễn dịch #tổn thương thiếu máu #ức chế miễn dịch #tái tạoTài liệu tham khảo
Starzl R, Brandacher G, Lee WP, Carbonell J, Zhang W, Schnider J, et al. Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation. Clin Dev Immunol 2013;2013:402980.
Harrison JH, Merrill JP, Murray JE. Renal homotransplantation in identical twins. Surg Forum 1956;6:432–6.
Merrill JP, Murray JE, Harrison JH, Friedman EA, Dealy JB Jr, Dammin GJ. Successful homotransplantation of the kidney between nonidentical twins. N Engl J Med 1960;262:1251–60.
Murray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ. Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 1963;268:1315–23.
Tobin GR, Breidenbach WC 3rd, Ildstad ST, Marvin MM, Buell JF, Ravindra KV. The history of human composite tissue allotransplantation. Transplant Proc 2009;41:466–71.
Robert G. Hand transplanted from cadaver is reamputated. Med Trib Med News 1964;5.
Murray JE. The first successful organ transplants in man. J Am Coll Surg 2005;200:5–9.
Borel JF, Kis ZL. The discovery and development of cyclosporine (Sandimmune). Transplant Proc 1991;23:1867–4.
Goto T, Kino T, Hatanaka H, Nishiyama M, Okuhara M, Kohsaka M, et al. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987;19:4–8.
Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87:401–11.
Ustüner ET, Zdichavsky M, Ren X, Edelstein J, Maldonado C, Ray M, et al. Long-term composite tissue allograft survival in a porcine model with cyclosporine/mycophenolate mofetil therapy. Transplantation 1998;66:1581–7.
Dubernard JM, Owen E, Herzberg G, Lanzetta M, Martin X, Kapila H, et al. Human hand allograft: Report on first 6 months. Lancet 1999;353:1315–20.
Strome M, Stein J, Esclamado R, Hicks D, Lorenz RR, Braun W, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med 2001;344:1676–9.
Kirschner MH, Brauns L, Gonschorek O, Bühren V, Hofmann GO. Vascularised knee joint transplantation in man: The first two years experience. Eur J Surg 2000;166:320–7.
Cavadas PC, Thione A, Carballeira A, Blanes M. Bilateral transfemoral lower extremity transplantation: Result at 1 year. Am J Transplant 2013;13:1343–9.
Barret JP, Gavaldà J, Bueno J, Nuvials X, Pont T, Masnou N, et al. Full face transplant: The first case report. Ann Surg 2011;254:252–6.
Devauchelle B, Badet L, Lengelé B, Morelon E, Testelin S, Michallet M, et al. First human face allograft: Early report. Lancet 2006;368:203–9.
Jiang HQ, Wang Y, Hu XB, Li YS, Li JS. Composite tissue allograft transplantation of cephalocervical skin flap and two ears. Plast Reconstr Surg 2005;115:31–5e.
Landin L, Cavadas PC, Nthumba P, Ibanez J, Vera-Sempere F. Preliminary results of bilateral arm transplantation. Transplantation 2009;88:749–51.
Hofmann GO, Kirschner MH. Clinical experience in allogeneic vascularized bone and joint allografting. Microsurgery 2000;20:375–83.
Doi K, Akino T, Shigetomi M, Muramatsu K, Kawai S. Vascularized bone allografts: Review of current concepts. Microsurgery 1994;15:831–41.
Hofmann GO, Kirschner MH, Buhren V, Land W. Allogenic vascularized transplantation of a human femoral diaphysis under cyclosporin A immunosuppression. Transplant Int 1995;8:418–9.
Birchall M. Tongue transplantation. Lancet 2004;363:1663.
Tintinago LF, Herrera DA, Medina E, Patiño JH, Cano F, Restrepo CS. Ultrasonographic evaluation of a vascularized tracheal transplantation. J Ultrasound Med 2005;24:1145–9.
Levi DM, Tzakis AG, Kato T, Madariaga J, Mittal NK, Nery J, et al. Transplantation of the abdominal wall. Lancet 2003;361:2173–6.
Hu W, Lu J, Zhang L, Wu W, Nie H, Zhu Y, et al. A preliminary report of penile transplantation. Eur Urol 2006;50:851–3.
Fageeh W, Raffa H, Jabbad H, Marzouki A. Transplantation of the human uterus. Int J Gynaecol Obstet 2002;76:245–51.
Health R. Services Administration, D.o.H. & Human, S. Organ procurement and transplantation network. Final rule. Federal Register 2013;78:40033–42.
Lantieri L, Hivelin M, Audard V, Benjoar MD, Meningaud JP, Bellivier F, et al. Feasibility, reproducibility, risks and benefits of face transplantation: A prospective study of outcomes. Am J Transplant 2011;11:367–78.
Diaz-Siso JR, Parker M, Bueno EM, Sisk GC, Pribaz JJ, Eriksson E, et al. Facial allotransplantation: A 3-year follow-up report. J Plast Reconstr Aesthet Surg 2013;66:1458–63.
Guo S, Han Y, Zhang X, Lu B, Yi C, Zhang H, et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008;372:631–8.
Hinojosa Pérez R, Porras López M, Escoresca-Ortega AM, Herruzo Avilés A, León A, Noval JA, et al. Severe rhabdomyolysis after allogeneic transplantation of facial structures: A case report. Transplant Proc 2010;42:3081–2.
Pomahac B, Pribaz J, Eriksson E, Annino D, Caterson S, Sampson C, et al. Restoration of facial form and function after severe disfigurement from burn injury by a composite facial allograft. Am J Transplant 2011;11:386–93.
Siemionow M, Papay F, Alam D, Bernard S, Djohan R, Gordon C, et al. Near-total human face transplantation for a severely disfigured patient in the USA. Lancet 2009;374:203–9.
Lantieri L, Meningaud JP, Grimbert P, Bellivier F, Lefaucheur JP, Ortonne N, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study. Lancet 2008;372:639–45.
Diaz-Siso JR, Bueno EM, Sisk GC, Marty FM, Pomahac B, Tullius SG. Vascularized composite tissue allotransplantation-state of the art. Clin Transplant 2013;27:330–7.
Dubernard JM, Lengelé B, Morelon E, Testelin S, Badet L, Moure C, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med 2007;357:2451–60.
Cavadas PC, Ibanez J, Thione A. Surgical aspects of a lower face, mandible, and tongue allotransplantation. J Reconstr Microsurg 2012;28:43–7.
Petruzzo P, Kanitakis J, Badet L, Pialat JB, Boutroy S, Charpulat R, et al. Long-term follow-up in composite tissue allotransplantation: In-depth study of five (hand and face) recipients. Am J Transplant 2011;11:808–16.
Schneeberger S, Gorantla VS, Brandacher G, Zeevi A, Demetris AJ, Lunz JG, et al. Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg 2013;257:345–51.
Breidenbach WC, Gonzales NR, Kaufman CL, Klapheke M, Tobin GR, Gorantla VS. Outcomes of the first 2 American hand transplants at 8 and 6 years posttransplant. J Hand Surg Am 2008;33:1039–47.
Schneeberger S, Gorantla VS, van Riet RP, Lanzetta M, Vereecken P, van Holder C, et al. Atypical acute rejection after hand transplantation. Am J Transplant 2008;8:688–96.
Cendales LC, Kanitakis J, Schneeberger S, Burns C, Ruiz P, Landin L, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 2008;8:1396–400.
Hautz T, Zelger BG, Weissenbacher A, Zelger B, Brandacher G, Landin L, et al. Standardizing skin biopsy sampling to assess rejection in vascularized composite allotransplantation. Clin Transplant 2013;27:E81–90.
Bejarano PA, Levi D, Nassiri M, Vincek V, Garcia M, Weppler D, et al. The Pathology of full-thickness cadaver skin transplant for large abdominal defects: A proposed grading system for skin allograft acute rejection. Am J Surg Pathol 2004;28:670–5.
Kanitakis J, Petruzzo P, Jullien D, Badet L, Dezza MC, Claudy A, et al. Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol 2005;15:235–8.
Schneeberger S, Kreczy A, Brandacher G, Steurer W, Margreiter R. Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H. Am J Transplant 2004;4:1372–4.
Cendales LC, Kirk AD, Moresi JM, Ruiz P, Kleiner DE. Composite tissue allotransplantation: Classification of clinical acute skin rejection. Transplantation 2006;81:418–22.
Lian CG, Bueno EM, Granter SR, Laga AC, Saavedra AP, Lin WM, et al. Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Mod Pathol 2014.
Iyer HS, Jackson AM, Zachary AA, Montgomery RA. Transplanting the highly sensitized patient: Trials and tribulations. Curr Opin Nephrol Hypertens 2013;22:681–8.
Petruzzo P, Lanzetta M, Dubernard JM, Landin L, Cavadas P, Margreiter R, et al. The international registry on hand and composite tissue transplantation. Transplantation 2010;90:1590–4.
Kanitakis J, McGregor B, Badet L, Petruzzo P, Morelon E, Devauchelle B, et al. Absence of c4d deposition in human composite tissue (hands and face) allograft biopsies: An immunoperoxidase study. Transplantation 2007;84:265–7.
Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: Where do we stand today? Transplantation 2012;93:855–9.
Chandraker A, Arscott R, Murphy GF, Lian CG, Bueno EM, Marty FM, et al. The management of antibody-mediated rejection in the first pre-sensitized recipient of a full-face allotransplant. Am J Transplant 2014.
Weissenbacher A, Hautz T, Zelger B, Zelger BG, Mayr V, Brandacher G, et al. Antibody-mediated rejection in hand transplantation. Transpl Int 2014;27:e13–7.
Kaufman CL, Ouseph R, Blair B, Kutz JE, Tsai TM, Scheker LR, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant 2012;12:1004–16.
Sinha I, Pomahac B. Split rejection in vascularized composite allotransplantation. Eplasty 2013;13:e53.
Pei G, Xiang D, Gu L, Wang G, Zhu L, Yu L, et al. A report of 15 hand allotransplantations in 12 patients and their outcomes in China. Transplantation 2012;94:1052–9.
Unadkat JV, Schneeberger S, Horibe EH, Goldbach C, Solari MG, Washington KM, et al. Composite tissue vasculopathy and degeneration following multiple episodes of acute rejection in reconstructive transplantation. Am J Transplant 2010;10:251–61.
Leonard DA, Kurtz JM, Mallard C, Albritton A, Duran-Struuck R, Farkash EA, et al. Vascularized composite allograft tolerance across MHC barriers in a large animal model. Am J Transplant 2014;14:343–55.
Tuuminen R, Syrjälä S, Krebs R, Keränen MA, Koli K, Abo-Ramadan U, et al. Donor simvastatin treatment abolishes rat cardiac allograft ischemia/reperfusion injury and chronic rejection through microvascular protection. Circulation 2011;124:1138–50.
Knight RJ, Dikman S, Liu H, Martinelli GP. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation 1997;64:1102–7.
de Groot H, Rauen U. Ischemia-reperfusion injury: Processes in pathogenetic networks: A review. Transplant Proc 2007;39:481–4.
Siemionow M, Arslan E. Ischemia/reperfusion injury: A review in relation to free tissue transfers. Microsurgery 2004;24:468–75.
Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Ann Rev Pharmacol Toxicol 1997;37:327–38.
Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review. Cardiovasc Surg 2002;10:620–30.
Morris SF, Pang CY, Zhong A, Boyd B, Forrest CR. Assessment of ischemia-induced reperfusion injury in the pig latissimus dorsi myocutaneous flap model. Plast Reconstr Surg 1993;92:1162–72.
Schlenker JD, Reus WF. Blood flow after warm ischemia in island flaps: Latissimus dorsi myocutaneous and epigastric flaps in the dog. Ann Plast Surg 1983;10:55–64.
Xiao B, Xia W, Zhang J, Liu B, Guo S. Prolonged cold ischemic time results in increased acute rejection in a rat allotransplantation model. J Surg Res 2010;164:e299–304.
Pradka SP, Ong YS, Zhang Y, Davis SJ, Baccarani A, Messmer C, et al. Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model. Transplant Proc 2009;41:531–6.
Caterson EJ, Lopez J, Medina M, Pomahac B, Tullius SG. Ischemia-reperfusion injury in vascularized composite allotransplantation. J Craniofac Surg 2013;24:51–6.
Pomahac B, Pribaz J, Eriksson E, Bueno EM, Diaz-Siso JR, Rybicki FJ, et al. Three patients with full facial transplantation. N Engl J Med 2012;366:715–22.
Timsit MO, Tullius SG. Hypothermic kidney preservation: A remembrance of the past in the future? Curr Opin Organ Transplant 2011;16:162–8.
Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009;360:7–19.
Timsit MO, Adams WJ, Laguna-Fernandez A, Ichimura T, Bonventre JV, García-Cardeña G, et al. Flow is critical for maintaining a protective phenotype in renal proximal tubular cells. Am J Transplant 2013;13:1617–8.
Gracia-Sancho J, Villarreal G Jr, Zhang Y, Yu JX, Liu Y, Tullius SG, et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: Strategies for pharmacologic intervention. Transplantation 2010;90:142–9.